4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxamide, 98%, 1g

4-Hydroxyphenyl glyoxal, 99.0%, 1g

1-(2-Bromophenyl)-2-methylpropan-2-amine, 98%, 1g

3,3',5,5'-Tetrabromo-2,2'-bithiophene, 98%, 25g

2-Amino-5-bromo-4-methylpyrimidine, 95.0%, 10g

Tungstophosphoric acid hydrate, pa, cryst., 500 g, glass packaging

2-Methoxy-3-(trifluoromethyl)benzamide, 1g

4-Hydroxybenzamide, 98.0%, 10g

Methyl 3-bromo-5-cyanobenzoate, 95.0%, 5g

2-(4-(DIFLUOROMETHYL)-3-FLUOROPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95.0%, 100mg

Ethyldiphenylphosphine, 95.0%, 25g

2-(Piperazin-1-yl)ethanamine, 95.0%, 25ml

Plan achromatic PLM 5x/0.14 LWD IOS objective. Working distance 10.8 mm. No cover glass correction